Reports

Drug name	NICE TAs	Comments
Diroximel fumarate	TA794: Diroximel fumarate for treating relapsing–remitting multiple sclerosis
Docetaxel injection	TA214 - Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer TA109 - Docetaxel for the adjuvant treatment of early node-positive breast cancer TA101 - Docetaxel for the treatment of hormone-refractory metastatic prostate cancer	Negative TA
Donepezil orodispersible tablets	TA217 - Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease	Dementia drugs ESCA
Donepezil tablets	TA217 - Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease	Dementia drugs ESCA
Doxorubicin injection	TA91 - Paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan for second-line or subsequent treatment of advanced ovarian cancer
Doxorubicin liposomal infusion	TA91 - Paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan for second-line or subsequent treatment of advanced ovarian cancer TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer	National CDF list
Dronedarone tablets	TA197 - Dronedarone for the treatment of non-permanent atrial fibrillation
Dupilumab	TA534 - Dupilumab for treating moderate to severe atopic dermatitis TA751 - Dupilumab for treating severe asthma with type 2 inflammation
Durvalumab	TA578 - Durvalumab for treating locally advanced unresectable non-small-cell lung cancer after platinum-based chemoradiation
Edoxaban	TA355 - Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation TA354 - Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism	First choice following a diagnosis of AF - use in line with NICE Anticoagulant Initiation Flowchart for Anticoagulation in Atrial Fibrillation

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
Next page
Last page

University Hospitals Birmingham NHS Foundation Trust

Medicines Formulary

Reports